Search clinical trials for: Revlimid
Total 588 results
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
Hackensack Meridian HealthCelgene CorporationTerminatedSmall Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia(CLL)United States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Joaquín Martínez López, MD, PhDHospital Infantil Universitario Niño Jesús, Madrid, SpainCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
Mikkael Sekeres, MDBristol-Myers Squibb; CelgeneRecruitingMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia
-
Stanford UniversityCelgene CorporationCompletedAcute Myeloid Leukemia (AML) | Adult Acute Myeloblastic LeukemiaUnited States
-
OncotherapeuticsTakedaTerminatedNewly Diagnosed Multiple MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
CelgeneTerminatedRenal Cell CarcinomaUnited States
-
Duke UniversityCelgeneTerminatedFollicular Lymphoma | Marginal Zone LymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); BeiGeneCompletedRecurrent Glioblastoma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | IDH1 Mutation | IDH2 MutationUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Stanford UniversityCelgene CorporationTerminatedLeukemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
Yale UniversityCelgene; Kyowa Kirin Co., Ltd.Completed
-
Brian JonasNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
Hospital Universitario GetafeUnknown
-
Heinrich-Heine University, DuesseldorfCelgene CorporationCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicGermany
-
University of Colorado, DenverCelgeneCompletedAcute Myeloid LeukemiaUnited States
-
French Innovative Leukemia OrganisationCelgene CorporationCompletedAcute Myeloid LeukemiaFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
Bial - Portela C S.A.Completed
-
Nordic MDS GroupUnknownMyelodysplastic Syndrome | Acute Myelogenous LeukemiaSweden
-
Samarkand State Medical InstituteActive, not recruitingAcute BronchiolitisUzbekistan
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Mayo ClinicNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMyelodysplastic Syndrome | MDSUnited States
-
M.D. Anderson Cancer CenterCelgeneTerminatedMalignant GliomasUnited States
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Mikkael Sekeres MDNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
Ohio State University Comprehensive Cancer CenterCureTech LtdTerminatedMultiple MyelomaUnited States
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization,... and other collaboratorsCompleted
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Monoclonal B-Cell Lymphocytosis | Stage I Small Lymphocytic LymphomaUnited States